Prediction of obstetric complications in women with hypertensive disorders of pregnancy

O.V. Vaskiv; O.H. Horbatiuk; A.P. Hryhorenko; V.V. Harbuziuk; O.L. Zhylko; T.V. Perebendiuk

doi:10.26641/2307-0404.2025.1.325354

Authors

O.V. Vaskiv National Pirogov Memorial Medical University,Vinnytsia,Ivana Puliuia str.,6,Khmelnytskyi, Ukraine https://orcid.org/0000-0001-6310-5692
O.H. Horbatiuk National Pirogov Memorial Medical University, Vinnytsia, Ivana Puliuia str., 6, Khmelnytskyi, 29016, Ukraine https://orcid.org/0000-0002-0123-367X
A.P. Hryhorenko National Pirogov Memorial Medical University, Vinnytsia, Ivana Puliuia str., 6, Khmelnytskyi, 29016, Ukraine https://orcid.org/0000-0003-3184-5359
V.V. Harbuziuk National Pirogov Memorial Medical University, Vinnytsia, Ivana Puliuia str., 6, Khmelnytskyi, 29016, Ukraine https://orcid.org/0000-0002-6104-7879
O.L. Zhylko National Pirogov Memorial Medical University, Vinnytsia, Ivana Puliuia str., 6, Khmelnytskyi, 29016, Ukraine https://orcid.org/0000-0001-9475-349X
T.V. Perebendiuk Khmelnytskyi Basic Medical Professional College, Proskurivska str., 37, Khmelnytskyi, 29000, Ukraine https://orcid.org/0009-0007-7537-4954

DOI:

https://doi.org/10.26641/2307-0404.2025.1.325354

Keywords:

gestational hypertensive disorders, gestational hypertension, preeclampsia, prognostic model, obstetric complications

Abstract

In the structure of maternal mortality causes, hypertensive disorders of pregnant women rank third. Hypertensive disorders of pregnant women can cause abortion and premature birth, fetal growth retardation, fetal hypotrophy, fetal hypoxia, premature detachment of a normally located placenta, and even fetal death. The aim of the study is to develop a mathematical model for predicting the risk of obstetric complications in women with gestational hypertensive disorders. Determination of independent predictors of obstetric complications of pregnancy and creation of a mathematical model for predicting the risk of obstetric complications in women with hypertensive disorders of pregnancy was performed using multiple stepwise linear regression analysis. Statistical analysis of the data was carried out according to standard methods using the «STATISTICA 5.5». In order to develop a mathematical model for predicting obstetric complications of pregnancy from the point of view of the influence of hypertensive disorders of pregnancy, data from a retrospective analysis of 60 women with hypertensive disorders of pregnancy were included in the multivariate statistical analysis. Women who had adverse obstetric outcomes of pregnancy (n=15) formed the main group (1-М). The group of women without complications of pregnancy and childbirth consisted of 45 people and was defined as a control group (1-C). The most significant independent predictors of obstetric complications of gestation in pregnant women with hypertensive disorders were identified, namely: systolic blood pressure, risk of preterm birth, primary manifestation of hypertensive abnormalities at 31-32 weeks of pregnancy, endothelin-1 concept in blood plasma and umbilical cord artery pulsatility index. It was found that the value of the multiple regression equation of the proposed model ≥503.38 points makes it possible to predict adverse obstetric outcomes of pregnancy in women with gestational hypertensive disorders in this pregnancy with a sensitivity of 73.3% and a specificity of 68.9%. Thus, the prognostic model developed by us with a fairly high sensitivity and specificity allows predicting obstetric outcomes of pregnancy in women with hypertensive disorders of pregnancy.

References

Bulavenko OV, Vaskiv OV. [Risk assessment of perinatal pathology in gestational hypertension]. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2017;1:277-80. Ukrainian.

Vaskiv OV. [Prediction of development and opti-mization of diagnosis of perinatal pathology in pregnant women with gestational hypertension]. [dissertation]. Ternopil: Ternopilskyi derzhavnyi medychnyi universytet im. IYa Horbachevskoho; 2022. 204 р. Ukrainian.

Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022;386(19):1817-32. doi: https://doi.org/10.1056/NEJMra2109523

Horbatiuk O, Hryhorenko A, Shatkovska A, Binkovska A, Vaskiv O. Using pentoxifylline, arginine hyd-rochloride, levocarnitine and rheosorbilact solutions for correction of fetoplacental dysfunction in pregnant women with preeclampsia. Reports of Vinnytsia National Medical University. 2021;25(1):88-93. doi: https://doi.org/10.1016/j.ajog.2024.03.012

Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta. Biomolecules. 2020;10(6):1-28. doi: https://doi.org/10.3390/biom10060953

Brownfoot F, Rolnik DL. Prevention of preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2024;93:102481. doi: https://doi.org/10.1016/j.bpobgyn.2024.102481

Liu YH, Zhang YS, Chen JY, Wang ZJ, Liu YX, Li JQ, et al. Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2023;228(5):535-46. doi: https://doi.org/10.1016/j.ajog.2022.10.014

Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104-10. doi: https://doi.org/10.1038/jhh.2009.45

Tan L, Kluivers ACM, Cruz-López EO, Broekhuizen M, Chen Z, Neuman RI, et al. Statins Prevent the Deleterious Consequences of Placental Chemerin Upre-gulation in Preeclampsia. Hypertension. 2024;81:861-75. doi: https://doi.org/10.1161/HYPERTENSIONAHA.123.22457

Griffin M, Heazell AEP, Chappell LC, Zhao J, Lawlor DA. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and preeclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies. Systematic Reviews. 2020;9:78.

doi: https://doi.org/10.1186/s13643-020-01334-5

Magee LA, Wright D, Syngelaki A, von Dadelszen P, Akolekar R, Wright A, et al. Preeclampsia pre-vention by timed birth at term. 2023 May;80(5):969-78. doi: https://doi.org/10.1161/HYPERTENSIONAHA.122.20565

Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226(2S):1108-19. doi: https://doi.org/10.1016/j.ajog.2020.08.045

Coffey CG. Issues in the interpretation of serum endothelin levels in preeclampsia. Medical Hypotheses. 2019;133:109400. doi: https://doi.org/10.1016/j.mehy.2019.109400

Cruz-Lemini M, Vazquez JC, Ullmo J, Llurba E. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226:1126-44. doi: https://doi.org/10.1016/j.ajog.2020.11.006

Vatansever D, Vatansever P, Giray B, Ertekin AA, Bilsel S. Do N-Terminal Pro-C-Type Natriuretic Peptide Levels Relate to Severity of Preeclampsia? International Jour¬nal of Hypertension. 2020;2020:2693534. doi: https://doi.org/10.1155/2020/2693534

Westerberg AC, Langeland Degnes M-H, Andresen IJ, Paasche Roland MC, Michelsen TM. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia. American Journal of Obstetrics and Gynecology. 2024 Nov;231(5):550.e1-550.e22. doi: https://doi.org/10.1016/j.ajog.2024.03.012

Prydannykova YЕ. Statistical Methods for Stu-dying the Causality between Economic Growth and Material Welfare of Populations. Scientific Bulletin of the National Academy of Statistics, Accounting and Audit. 2017;3:16-25. doi: https://doi.org/10.31767/nasoa.3.2017.02